论文部分内容阅读
目的 评价紫杉醇慢速释放支架的近期安全性及效果。方法 71例患者共处理 1 4 8处病变 ,置入支架 1 71枚 ,其中 1 0 2处病变置入 1 32枚TAXUSTM支架。结果 1处病变TAXUSTM支架不能通过 ,其余全部成功置入。手术过程及住院期间无并发症发生。随访 6个月无新出现的缺血性心脏事件及新出现的心肌缺血的心电图证据。结论 TAXUSTM支架应用的近期安全性较高 ,使用方便 ,近期效果较好 ,但是长期安全性及效果尚待验证。
Objective To evaluate the recent safety and efficacy of paclitaxel slow release stent. Methods A total of 148 lesions were treated in 71 patients. A total of 171 scaffolds were placed, of which 102 TAXUSTM stents were placed in 102 lesions. Results 1 lesions TAXUSTM stent can not pass, the rest all successfully inserted. No complications during the operation and hospitalization. There were no new ischemic heart events and new ECG evidence of myocardial ischemia at 6 months follow-up. Conclusion TAXUSTM scaffolds have higher safety and ease of use in the near future, but their long-term safety and efficacy have yet to be validated.